LEIPZIG, Germany and ATLANTA, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that ...

81% of shippers and logistics services providers view transportation as a competitive weapon; growth and AI adoption driving investments despite automation gap LONDON and ATLANTA, Sept. 15, 2025of ...

The Italian mobile application developer Bending Spoons S.p.A. today announced its intent to acquire the YouTube rival Vimeo.com Inc. in an all-cash deal worth around $1.38 billion. Bending Spoons ...

Descartes Systems Group's growth model combines organic expansion with frequent M&A, driving impressive revenue growth but leading to persistently high valuation multiples. Recent organic growth has ...

36th Annual State of Logistics Report: Navigating uncertainty amid rising costs and global disruptions The 36th Annual State of Logistics (SoL) Report highlights a logistics market tested by economic ...

Supply chain software provider Descartes Systems Group announced it has acquired cloud-based inventory management company Finale Inventory. The deal includes an upfront payment of approximately $40 ...

Video hosting and sharing platform Vimeo today announced the launch of an updated Apple TV app, bringing Vimeo back to the Apple TV App Store for the first time in two years. The updated Vimeo app has ...

Canadian logistics software provider Descartes Systems Group has expanded its final-mile capabilities with the acquisition of PackageRoute. The cash deal was valued at about US$2 million. PackageRoute ...

The Descartes Systems Group Inc. excels in logistics tech, leveraging AI and compliance solutions, but faces slowing organic growth and margin pressure amid industry disruption. Recurring revenue ...

Vimeo CEO Philip Moyer (left) spoke onstage with Fortune’s Kristin Stoller (right) at SXSW in Austin, Texas on March 11. Heidi Jackman/Vimeo “This time last year, a lot of the content of the world was ...

A first person has been dosed with the therapy, Descartes-08, for treatment of systemic lupus erythematosus (SLE). The therapy has previously been used to treat people with myasthenia gravis, a ...

Cartesian Therapeutics, Inc, a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, announced that the first patient has been dosed in its phase 2 open-label ...